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Summary.-Hooded Lister/Cbi rats bearing the HSN.TC fibrosarcoma produced a
high-titre non-complement-binding IgG antibody, and tests in vitro indicated that
the syngeneic antibody was specificforthis tumour. About 1-4 x 105antibodymolecules
were bound per cell, a figure one eighth that for cells treated with a high-titre allo-
antiserum. When tumour-bearer serum was passively transferred into congenitally
athymic rats bearing the HSN.TC tumour the antibody was absorbed out speci-
fically, by comparison with control animals or athymic rats bearing an unrelated
tumour that was also syngeneic in Hooded rats. The kinetics of loss of antibody from
the surface of HSN.TC cells has been monitored in vitro and the antibody has been
found to have an extended half-life at the cell surface (>40 h).
THE METASTASIS of chemically induced
tumours in experimental animals can be
influenced by the host's immune system.
Tumours that show a low rate of spon-
taneous metastasis in the immunocom-
petent host, have been found to exhibit
rapid and widespread dissemination in
animals that (a) are congenitally athymic
(Eccles et al., 1979) (b) have been T-cell-
deprived by thymectomy and sub-lethal
irradiation (Eccles & Alexander, 1974) or
(c) have been immunosuppressed by treat-
ment with cyclosporin A (Eccles et al.,
1980). In one such model system (the
HSN.TC fibrosarcoma grown in syngeneic
Hooded rats) we have found (Eccles et al.,
1979) that when this tumour was grown in
athymic rats, they failed to produce the
specific serum antibody normally found
in immunocompetent animals, and were
also defective in the recruitment of mono-
nuclear phagocytic cells. Currently we are
attempting to define the role of humoral
factors in metastatic disease, and in this
communication report further on the
specific antibodies that are produced in
Hooded rats during the growth of the
HSN.TC fibrosarcoma. In particular, we
have compared the rates of clearance
from circulation of these antibodies after
i.v. injection into normal or tumour-
bearing animals and have examined the
half-life of the antibodies at the surface
ofcultured tumour cells.
MATERIALS AND METHODS
Animals.-Inbred rats of the following
strains were taken from our own barrier-
maintained colony: ListerHooded/Cbi (RT1C),
WVistar (RTIV) and athymic nudes derived
from a Rowett (rnu/rnu) x Lister Hooded/
Cbi cross, now at the 5th backcross genera-
tion.
Tumouars anid cell cultures-Two fibro-
sarcomas were used, both syngeneic to
Hooded/Cbirats, HSN.TC-a3,4-benzpyrene-
induced tumour (Currie & Gage, 1973) and
MC24, a 20-methylcholanthrene-induced tum-
our (Eccles et al., 1980). They were passaged
routinely by implantation in the hind leg
of Hooded rats. Cells for culture in vitro were
obtained by trypsinization oftumourexplants
and grown routinely in Fischer's medium
containing 1000 heat-inactivated foetal calf
serum (FCS), 500 i.u./ml penicillin, 50 ,ug/ml
streptomycin, 100 ,tg/ml neomycin and sup-CELL-BOUND ANTIBODIES IN RATS
plemented with 50 u/ml mycostatin. To
re-establish these tumours in vivo, cultured
cells were injected into 12-week-old rats at a
dose of 5-10 x 105 cells per animal, given
i.m. into one hind leg.
For testing the specificity of antisera,
short-term cultures of the following rat
fibrosarcomas were established in vitro:
HSBPA and ASPB1 (3,4-benzpyreneinduced)
MC24, MC32 and MC33 (20-methylcholan-
threne induced). With the exception of the
August rat sarcoma (ASBP1) these tumours
were syngeneic with Lister Hooded/Cbi rats.
Cultures of normal rat fibroblasts were
obtained by trypsinization of xiphisternae
from Lister Hooded/Cbi rats (HOXI-RTle
haplotype) and Lou/Wsl rats (LOXI-RTIv
haplotype).
Antisera.-Alloantisera were raised by
immunizing 10-week-old Wistar rats at 10-
day intervals with 5 x 107 cultured tumour
cells per rat, distributed over 4 sites i.m.
and one i.p. The animals were exsanguinated,
by cardiac puncture under anaesthesia, 10
days after the last immunization. Syngeneic
anti-HSN.TC sera were obtained from tum-
our-bearing Hooded rats. Sera obtained from
age- and sex-matched normal Wistar or
Hooded rats were used as controls. The sera
were decomplemented where necessary by
heating at 5600 for 45 min.
Detection and quantification of cell-bound
antibodies.-Specific antibodies bound to cell
surfaces were determined, either directly with
an antiglobulin-binding assay, or by competi-
tive radioimmunoassay (RIA) after lysis of
the cells in sodium deoxycholate.
Tumour cells were grown as monolayers,
either in Falcon No. 3040 Microtest II plates
(Becton Dickinson, Oxnard, Cal., U.S.A.)
or in multiwell plates (No. 313, Sterilin,
Richmond, Surrey) containing Fischer's med-
ium supplemented with 10% FCS and 18 mm
HEPES. In the antiglobulin-binding assay
(Hall et al., 1979) cell monolayers were
exposed for 1 h to dilutions of antisera or
normal rat serum in medium, washed twice
and incubated in fresh medium at 00C for
30 min. After a further wash, cell-bound
antibodies were determined by incubation
with 125J-labelled, specifically purified anti-
bodies directed against rat immunoglobulins
of classes IgM, IgA and IgE, subclasses IgGi
and IgG2 or against rat F(ab')2. In all
experiments the amount of specific antibody
bound was determined by subtracting ct/min
bound by cells treated with normal sera from
ct/min bound by cells treated with immune
sera.
For quantitative estimation of cell-bound
antibody by RIA, the washed, sensitized
monolayers in multiwell plates were lysed by
incubation for 30 min at 20°C with 0 5 ml
of -0O1m Tris buffer (pH 8.2) containing 1%
sodium deoxycholate, 0.5% bovine serum
albumin, 10-3M phenylmethylsulphonyl fluor-
ide, and 100 ,ugDNAse (Sigma, Poole, Dorset).
Rat immunoglobulins present in the samples
were quantitated by a solid-phase RIA,
employing rabbit anti-rat F(ab')2 linked to
DASP anti-rabbit (Organon-Technika, Hun-
tingdon) and using 1251-labelled rat IgG2 as
antigen (Styles, 1978).
Monolayers of antibody-coated cells were
tested for complement-fixing antibodies,
either by using the 1251-Clq-binding assay or
by monitoring the lysis of 51Cr-labelled cells
(Shepherd & Dean, 1979).
Clearance of syngeneic anti-HSN.TC anti-
body in vivo.-Fibrosarcomas HSN.TC and
MC24 were established in 12-week-old nude
female Lister Hooded/Cbi rats, with age- and
sex-matched non-tumour-bearing nudes as
controls. Twenty-one days later, when the
tumours were 1 5-2 cm in diameter, 1 ml of
syngeneic anti-HSN.TC serum, obtained from
Hooded rats that had borne this tumour for
21 days, was injected i.v. into each animal.
Blood samples were taken from the jugular
vein during the subsequent week and the
resulting sera were tested, by the antiglobulin
assay, for the presence ofantibody that would
bind specifically to monolayers of HSN.TC,
using as controls samples of serum taken
from each animal before the specific antiserum
was injected.
Clearance of syngeneic anti-HSN.TC anti-
body in vitro.-Experiments of two types
were performed with HSN.TC cells grown as
monolayers in Microtest II plates.
In the first series of experiments, cells were
exposed for 1 h at 370C to dilutions in medium
of the syngeneic antiserum or normal rat
serum. They were then washed x 3 and incu-
bated in fresh medium at 37°C. Samples were
taken at intervals, the medium was discarded,
and the quantity of rat antibody remaining
bound to the cell surface was assayed with the
antiglobulin assay. The quantity of specific
antibody bound was determined after cor-
rection for that bound by cells treated with
normal rat serum.
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In the second series, HSN.TC cells were
exposed continuously to the dilutionis of test
and control sera at 37°C. Samples wA-ere taken
at intervals, the cells were washed x 3 and
the amount of cell-bound antibodv was
estimated as before.
RESULTS
Specificity of the antibodies to HSV.TC
We have conducted two types of test
to establish the tumour-specificity of the
syngeneic antibodies to HSN.TC. In the
first, samples ofserum taken from animals
after 21 days oftumour growth or 15 days
after tumour excision, were tested in vitro
by titration on monolayers of 6 fibro-
sarcoma and 2 normal fibroblast cell lines.
The binding of 1251 anti-F(ab')2 by cells
that had been treated with a 1/80 dilution
of either normal or immune serum is
shown in Table I. The results show that,
only the HSN.TC gave specific binding of
antibodies from tumour bearer and post-
amputation sera.
Table I shows also that antibodies in
the hyperimmune alloantiserum (RTI v
and RT1c) bound to all cells of the RT1c
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haplotype but not fibroblasts of the RT1I
haplotype.
To extend the specificity testing, we
have monitoredthe clearance ofthe specific
antibodies to HSN.TC from circulation
following their injection i.v. into control
or tumour-bearing nude rats. We have
used nude rats in these experiments
because they (a) normally show low levels
of serum immunoglobulins and (b) do not
produce antibodies against the HSN.TC
tumour (Eccles et al., 1979), features
facilitating the subsequent detection of
injected antibodies.
Seven nude rats bearing the HSN.TC
tumour, 2 bearing the MC24 tumour and
4 non-tumour-bearing animals, each re-
ceived 1 ml of a high-titre Hooded anti-
HSN.TC i.v. Serum samples were taken
over a period of 1 week and titrated for
specific antibodies. The results (Fig. 1)
show that controls and animals bearing
the MC24 tumour cleared the specific
antibodies slowly with an extrapolated
half-life of about 15 days, whereas the
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FIG. I. Clearance of syngeneic antibodlies
to HSN.TC in vivo. Nude rats bearing the
HSN.TC tumour (0), the MC24 tumour
(M) or no tumour ( w) were given 1 ml of
21-day HSN.TC tumour bearer serum i.v.,
and the quantity of antibody remaining in
circulation w,as estimated by titration of
serum samples on cultured HSN.TC cells.
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FIG. 2.-Titration of specific antibodies in
the serum ofHooded Lister/Cbi rats 21 clays
after challenge with HSN.TC tumour.
Assays were performedI on confluent mono-
layers of HSN.TC cells, using 1251-labelled
antibodies t.o JgG2 (0) IgGi (0), IgMl
(-), IgA (A) or TgE (-).
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animals bearing the HSN.TC tumour
showed specific clearance with a half-life
of about 5 days.
Isotype distribution of anti-HSN.TC serumn
antibody
Samples of serum taken at intervals
during growth of the HSN.TC fibro-
sarcoma were tested for anti-HSN.TC
activity by the antiglobulin-binding assay.
At no time were we able to detect
significant amounts of anti-HSN.TC anti-
bodies of the IgA or IgE classes, though
specific IgA antibodies were detected in
the bile of rats bearing this tumour along
the gut (Gyure et al., 1980). We could not
demonstrate the presence of complement-
fixing antibodies by either test used. The
anti-HSN.TC antibodies were largely of
the IgG2 subclass (Fig. 2) though lower
levels of IgG1 could be detected in all
samples taken from 7 days onwards. IgM
antibodies were found infrequently and
were oflow titre.
Concentration of tumour antigens at the
cell surface
Confluent monolayers of HSN.TC cells
were sensitized with dilutions of allo-
0
antiserum, syngeneic anti-tumour serum
or normal sera. After thorough washing
to remove unbound immunoglobulin, the
cells were lysed with deoxycholate and the
quantity of immunoglobulin present esti-
mated by RIA. To determine the quantity
of specific cell-bound antibody at satura-
tion, Scatchard plots of the data (cor-
rected for non-specific binding of control
sera) were made by using as the value for
"free antibody" the quantity of serum
immunoglobulin added per 106 cells.
From these plots (Fig. 3) we estimate that
a monolayer of 106 cells binds - 300 ng of
alloantibody and , 36 ng of anti-tumour
antibody. Assuming that the antigens are
monovalent and that at saturation 1
antibody molecule binds to 1-2 molecules
of antigen, the results yield a value of
1*4-2 8 x 105 molecules of tumour antigen
per cell surface exposed in a monolayer
culture, and about 8 times this value for
the number of exposed alloantigens.
Half-life of cell-bound anti-HSN.TC anti-
body in vitro
The relatively slow specific clearance of
antibodies in HSN.TC-bearing nude rats
(Fig. 1) could have been caused by the
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FIG. 3.-Scatchard plots of the quantities of specific immunoglobulin bound by 106 HSN.TC cells after
their treatment with either RTIv anti-RTIc serum (A) or the syngeneic antiserum to HSN.TC (B).CELL-BOUND ANTIBODIES IN RATS
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FIG. 4.-Clearance of alloantibodies (closed
symbols) and syngeneic anti-tumour anti-
bodies (open symbols) from the surface of
HSN.TC cells. Monolayers were sensitized
for 1 h with 1/20 (circles); 1/40 (triangles);
1/80 (squares) or 1/160 (inverted triangles)
dilutions of antisera or normal rat sera
and then incubated in fresh medium at
37°C. Cell-bound antibody was determined
using 1251 sheep/rat F(ab')2.
failure of the antibodies to interact
efficiently with the cells of the tumour, or
by the slow clearance of surface-bound
antibodies by the tumour cells themselves.
To investigate this problem we examined
the behaviour of cultured HSN.TC cells
exposed for 1 h to the syngeneic anti-
serum, washed and then incubated under
conditions suitable for cell growth. We
have compared these results with those
from the same batch of cells treated in
the same manner with a high-titre allo-
antiserum.
The results of a typical experiment are
illustrated in Fig. 4, which shows the
specific antibodies bound to the cells
(monitored with 1251-sheep/rat F(ab')2) at
various times during incubation after
sensitization. The data show that cells
treated with anti-tumour serum had a
slow exponential rate of disappearance of
surface-bound antibody, with a half-life
of - 60h.
The results obtained in several experi-
ments are detailed in Table II. Similar
slow clearances were obtained if an Fe
specific reagent (1251-sheep/rat IgG2) was
substituted for the anti-F(ab')2 reagent,
indicating that the antibodies remaining
at the cell surface were intact immuno-
globulins. These results contrast with the
behaviour of cells treated with allo-
antiserum, where the loss of cell-surface
antibody was faster and took place in
two well-defined stages (see Fig. 4). The
first phase was rapid, with up to half of
the bound antibody having been cleared
from the cell surface by 7-10 h. Although
the remaining fraction was cleared more
slowly (half-life 22-36 h, see Table II) the
rate was still faster than that of the anti-
HSN.TC antibodies. No loss of antibody
was found, however, when the cells were
incubated for 4 h at 0°C (data not shown)
showing that loss of low-affinity antibody
TABLE II.-Clearance of Allo- and syngeneic antitumour antibodies in vitro*
Wistar anti-HSN
% initial antibody Half-life
still bound at 8 h (h)1
68 36
66 32
63 25
72 26
46 37
48 22
HSN tumour-bearer serum
% initial antibody
still bound at 8 h
92
87
71
92
65
84
* Using 1251 sheep/rat F(ab')2
t Using 1251 sheep/rat IgG2.
I From the slope of the exponential part of the clearance curve.
Expt No.
24-5
28-6
18-7
9-8
22-8
13-12
Half-life
(h)
61
70
48
44
63
45
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3 (b) were inot absorbed out by an unrelated
tumour and (c) were absorbed out in
animals bearing the HSN.TC tumotur.
The conmplexes formed between syn-
A?s v v geneic antibody and HISN.TC cells showedl
2c 2 L a considerable lifetime at the cell suirface
E.1 ^° , * in vitro, surviving more than one cell
A *(l^ division. The similaritv of the data
obtained for antibody clearance, using
either the anti-F(ab')2 or anti-Fe reagents, ,Dfi 1 - indicate that the antibodies remaining at
the cell sturface were intact, and therefore
probably retained their biological func-
tion. The persistence of the bound anti-
bodies at the tuimour-cell surface would
20 40 60 80 explain the relatively slow rate of specific
HOURS clearance in vivo of passively transferred
FIG. 5.--Failure of tumour antibody to antibody, if cell-surface clearance is rate-
modulate HSN.TC antigens. Alonolayers limiting for this process, and mav also of HSN.TC were incubated continuously
in 1/20 (0), 1/40 (0), 1/80 (A) or 1/160 contribute to the high levels of serum
(A), dilutions of 21-day tumour-bearer antibody in tumour-bearers.
serum. Specific cell-boun(d antibody anasti-
leterminecd using 125f-shleep/rat rF(ab')2 Th)9w laaneo sngei anti
body from the cell surface, and the
fcailure to ccause modulation of this axnti- (cf. Taylor et al., 1979) was not responsible ue wl be mortant of the eftor
fr the inta rapi cleaanc. gen, will be important for the effector-
function of the antibody in vivo (i.e.
Is the HSX.TC tumour-associated antigen interaction with complement components
modulated in vitro? and phagocvtic and other Fe-receptor-
bearing cells) and these properties couldk
To discoverwrhether continuedlexposure be advantageouIs if the antibodies have a
to anti-tumour antibodies would lead to role in preventing tumour-cell dissemina-
an altered expression of the ttumour- tion. CutrrentlyN, we are testing this pos-
associated antigen (Old et al., 1968) sibility in nutide rats, where wve have shown
cultures of HSN.TC were incubated for (Eccles et al., 1979) thLat in the absence of
up to 72 h in the presence of syngeneic anlimmutnie response, the HSN.TC tumour
antibody. Cell-bound antibody was detec- undergoes rapi(d and extensive metastasis
ted throughout incubation (Fig. 5) and to the ltungs.
no evidence was obtained that this treat- The experiments reported here also
ment led to reduced levels of tumoulr irevealed (lifferences in the rates of clear-
antigen at the cell surface. ance of allogeneic and syngeneic anti-
bodies, suggesting that immune com-
DISCUSSION plexes formed between (ifferent surface antigens are handled independentlv. We have shown that H-oodedl rats Althotugh the alloantibodies were cleare'd
bearing the HSN.TC fibrosarcoma have a faster than the svngeneic antibodies to
serum antibody that binds specifically to HSN.TC, their half-life at the cell suirface
cultured HSN.TC cells. The data obtained was still considerable. These results are
following passive transfer of this anti- puzzling in the light of current evidence
serum into nude rats showed that the that the plasma membrane undergoes
antibodies were specific, becauise they: continuouis internalization dcuring the
(a) had a long half-life in control animals. formation of endocytic vesicles and pha-CELL-BOUND ANTIBODIES IN RATS 197
golysozomes (Schneider et al., 1979;
Muller et al., 1980). Subsequently, many
of the internalized membrane compo-
nents are recycled to the cell surface. The
fact that recycling times for plasma mem-
brane proteins have been estimated as
30 min or less (Muller et al., 1980) suggests
that our antigen-antibody complexes are
either not internalized or they must be
recycled repeatedly during their apparent
lifetime at the cell surface. Currently, this
aspect is under investigation.
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